Kerkhof, MarjanChaudhry, IshaPavord, Ian D.Miravitlles, MarcRhee, Chin KookHalpin, David M.G.Usmani, Omar S.Jones, RupertKocks, JanwillemAlacqua, MariannaMorris, TamsinKaplan, AlanPrice, David B.2020-11-192020-11-192020Kerkhof, M, Chaudhry, I, Pavord, I D, Miravitlles, M, Rhee, C K, Halpin, D M G, Usmani, O S, Jones, R, Kocks, J, Alacqua, M, Morris, T, Kaplan, A & Price, D B 2020, 'Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD', ERJ Open Research, vol. 6, no. 4. https://doi.org/10.1183/23120541.00188-20202312-0541https://hdl.handle.net/2164/15384ACKNOWLEDGEMENTS This study was funded by AstraZeneca. Editorial support was provided by Joanne M. Faysal, MS, and Jennie G. Jacobson, PhD, CMPP, of JK Associates, Inc., and Michael A. Nissen, ELS, of AstraZeneca. This support was funded by AstraZeneca. DATA-SHARING STATEMENT Data underlying the findings described in this manuscript may be requested in accordance with AstraZeneca’s data-sharing policy described at https://astrazenecagroupdt.pharmacm.com/DT/Home12867471engCOPDeosinophilshospitalisationCOPD treatmentExacerbationsR Medicine (General)R1Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPDJournal article10.1183/23120541.00188-202064